February 20, 2016
Bowel Cancer New Zealand believes screening using sigmoidoscopy is a distraction from the pressing need for a national screening program.
Bowel Cancer New Zealand (BCNZ) spokesperson Mary Bradley says “New Zealand is far behind other OECD countries in implementing a bowel screening programme, the last thing we need to do is further delay things by changing direction now”.
The Ministry of Health has taken extensive advice on this issue and the balance of evidence, international opinion, and cost-effectiveness favour faecal immunochemical test(FIT) screening.
Sigmoidoscopy misses a third of cancers unable to be viewed by the sigmoidoscope.
Bowel Cancer New Zealand’s concern now is that the demonstrable success of the Waitemata DHB pilot of FIT is made available to all New Zealanders by rolling out that programme nationally.
“We see no reason to back up the bus and start from scratch. The government needs to get on with implementing a national screening programme now; 1200 New Zealander’s continue to die of bowel cancer every year they delay,” says Bradley.
BCNZ encourages open discussion about bowel cancer with medical professionals and avoiding ‘sitting on your symptoms’. Symptoms include:
• Bleeding from the bottom or seeing blood in the toilet after a bowel motion;
• Change of bowel motions over several weeks without returning to normal;
• Persistent or periodic severe pain the abdomen;
• A lump or mass in the abdomen;
• Tiredness and loss of weight for no particular reason;
Those who don’t live in the Waitemata DHB area or have symptoms or a family history of bowel cancer and want to do regular checks can talk to their GP or buy a commercially available bowel screening kit, which involves the family doctor, at Life or Unichem pharmacies.